Literature DB >> 7243439

The velo-cardio-facial syndrome: a clinical and genetic analysis.

R J Shprintzen, R B Goldberg, D Young, L Wolford.   

Abstract

Thirty-nine patients with the velo-cardio-facial syndrome are described in order to further delineate this probably common recurrent pattern congenital malformation syndrome. Frequent features include cleft palate, cardiac anomalies, typical facies, and learning disabilities. Less frequent findings include microcephaly, mental retardation, small stature, slender hands and digits, minor auricular anomalies and inguinal hernia. Ths Robin malformation sequence was found in four patients. The congenital heart anomalies most frequently involved a ventricular septal defect, with or without a right-sided aortic arch. There were four instances of familial transmission in the sample population. These included two cases of maternal transmission of the syndrome to daughters, one case of maternal transmission to a son, and one case of maternal transmission to both a son and daughter. There was no particular difference in expression between male and female patients so that even though X-linked dominant transmission is possible, the velo-cardio-facial syndrome is likely to be an autosomal dominant recurrent pattern syndrome.

Entities:  

Mesh:

Year:  1981        PMID: 7243439

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  59 in total

1.  Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome.

Authors:  S Cannavò; L Bartolone; D Lapa; M Venturino; B Almoto; A Violi; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

2.  Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 Microduplications.

Authors:  J Wincent; D L Bruno; B W M van Bon; A Bremer; H Stewart; E M H F Bongers; C W Ockeloen; M H Willemsen; D D A Keays; G Baird; D F Newbury; T Kleefstra; C Marcelis; U Kini; Z Stark; R Savarirayan; L J Sheffield; O Zuffardi; H R Slater; B B de Vries; S J L Knight; B-M Anderlid; J Schoumans
Journal:  Mol Syndromol       Date:  2011-05-18

3.  Lower prepulse inhibition in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Maria Karayiorgou
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

4.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

Authors:  Christiane Zweier; Heinrich Sticht; Inci Aydin-Yaylagül; Christine E Campbell; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

5.  Anal anomalies: an uncommon feature of velocardiofacial (Shprintzen) syndrome?

Authors:  S Worthington; A Colley; K Fagan; K Dai; A H Lipson
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

6.  Velocardiofacial syndrome: learning difficulties and intervention.

Authors:  L L Kok; R T Solman
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

Review 7.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

8.  22q11 deletions in isolated and syndromic patients with tetralogy of Fallot.

Authors:  F Amati; A Mari; M C Digilio; R Mingarelli; B Marino; A Giannotti; G Novelli; B Dallapiccola
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

9.  Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Thomas R Kwapil; Jessica Kaczorowski; Margaret N Berry; Cesar S Santos; Timothy D Howard; Dhruman Goradia; Konasale Prasad; Diwadkar Vaibhav; Rajaprabhakaran Rajarethinam; Edward Spence; Matcheri S Keshavan
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

10.  Sex differences in the behavior of children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Samantha Hadley Monk; Jananne Khuri; Maria Karayiorgou
Journal:  Psychiatry Res       Date:  2009-02-14       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.